ArticleBlood2013

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.

Shimin Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.